News | September 25, 2024
Nadda asked NMC to add 75,000 medical seats
NMC to continue its efforts to improve and enhance the quality of medical education in the country
NMC to continue its efforts to improve and enhance the quality of medical education in the country
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
This license will enable Abbott to enhance access to this novel therapy to more patients across India
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Subscribe To Our Newsletter & Stay Updated
